EUVIMED · CrossrefJournal
Asia-Pacific Journal of Clinical Oncology
ISSN 1743-7555 · Wiley
Latest articles
Contribution of Focal 1 8 F‐FDG Uptake on Positron Emission Tomography/Computed Tomography to Ultrasonography‐Based Malignancy Risk Assessment in Incidentally Detected Thyroid Nodules
Risk Factor Profiles May Differ Between Younger‐Onset and Late‐Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort
Transarterial Chemoembolization and Chemo‐Immunoembolization in Locally Advanced Rectal Cancer: An Updated Systematic Review
Real‐World Toxicity and Outcomes of KEYNOTE‐522‐Style Neoadjuvant Pembrolizumab for Triple‐Negative Breast Cancer in Australia
Convenor Welcome
COSA Committees
Highlighted Lectures and Awards
International Invited Speakers
Sponsor Acknowledgments
National Speakers
Program in Detail
Poster Listing
Exhibitor Listing
Oral Abstracts
Author Listing
Poster Abstracts
Issue Information
Divergent Trends in Head and Neck Cancer Burden in China (1990–2021)
Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment
Selective Serotonin Receptor (5‐HT3) Antagonist Prescribing in Cancer Inpatients: A Retrospective Clinical Audit
Real‐World Efficacy of Postoperative Adjuvant Nivolumab in High‐Risk Urothelial Carcinoma: A Retrospective Comparative Study in an Asian Population
Quality of Life in Breast and Gynecological Cancer: A Review of Systematic Reviews, 1985–2025
Comprehensive Genomic Profiling Timeliness Beyond Laboratory Turnaround Time: A Patient‐Facing Pathway Analysis
Personalized Cancer Vaccines in the Clinical Trial Pipeline
Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Older Versus Younger Patients With Unresectable Pancreatic Cancer: The Multicenter NAPOLEON‐2 Study
Endosomal Entrapment: The Silent Failure Point of Cancer Nanotherapeutics and How Pharmaceutical Design Can Overcome It
Pan‐Cancer Analysis and Functional Characterization Identify SLC15A4 as a Novel Prognostic Biomarker and Therapeutic Target
Implementing Teletrials to Improve Equity of Access for Regional Patients With Cancer: Report From the Victorian Teletrial Collaborative
The MASCC COG‐IMPACT: The COSA Endorsement of a MASCC Developed Unmet Needs Assessment Tool for Cancer‐Related Cognitive Impairment Impact
Impact of Metformin and Diabetes on Tumor Response to Total Neoadjuvant Therapy in Advanced Rectal Cancer: A Multicenter Retrospective Cohort Study
EUVIMED